NCT02015000

Brief Summary

The treatment of pterygium is still quite controversial. Previous studies using a large incision for pterygium excision and a large graft and has reported a very low recurrence rate with the P.E.R.F.E.C.T. technique. However, the P.E.R.F.E.C.T. technique is a relatively lengthy procedure and may not be suitable for patient with limited conjunctival reserve. Thus, we try to evaluate the final outcome of a sutureless amniotic membrane transplant technique combining the extended pterygium excision in hope to avoid the complication of the P.E.R.F.E.C.T. for PTERYGIUM technique.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2013

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

December 8, 2013

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 19, 2013

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2014

Completed
Last Updated

December 19, 2013

Status Verified

December 1, 2013

Enrollment Period

1 month

First QC Date

December 8, 2013

Last Update Submit

December 12, 2013

Conditions

Keywords

PterygiumRecurrence

Outcome Measures

Primary Outcomes (1)

  • Recurrence of pterygium

    defined as proliferating conjunctival tissue was found extending the limbus more than 1 mm onto the cornea within the surgical field )

    1 year

Secondary Outcomes (1)

  • caruncular morphology

    1 year

Study Arms (1)

pterygium recurrence

EXPERIMENTAL

Surgical Result of Primary and Recurrent Pterygium by Using Pterygium Extended Removal followed by Fibrin Glue Assisted Amniotic Membrane Transplantation (P.E.R.F.A.M.T)

Procedure: P.E.R.F.A.M.T

Interventions

P.E.R.F.A.M.TPROCEDURE

Surgical Result of Primary and Recurrent Pterygium by Using Pterygium Extended Removal followed by Fibrin Glue Assisted Amniotic Membrane Transplantation (P.E.R.F.A.M.T)

pterygium recurrence

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient with pterygium
  • Operated by single surgeon (Chen, Wei-Li)

You may not qualify if:

  • Follow-up time less than 12 months
  • Age less then 18 year-old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, Taipei City, 100, Taiwan

RECRUITING

Related Publications (2)

  • Hirst LW. Prospective study of primary pterygium surgery using pterygium extended removal followed by extended conjunctival transplantation. Ophthalmology. 2008 Oct;115(10):1663-72. doi: 10.1016/j.ophtha.2008.03.012. Epub 2008 Jun 16.

    PMID: 18555531BACKGROUND
  • Hirst LW. Recurrent pterygium surgery using pterygium extended removal followed by extended conjunctival transplant: recurrence rate and cosmesis. Ophthalmology. 2009 Jul;116(7):1278-86. doi: 10.1016/j.ophtha.2009.01.044.

    PMID: 19576496BACKGROUND

MeSH Terms

Conditions

PterygiumRecurrence

Condition Hierarchy (Ancestors)

Conjunctival DiseasesEye DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Wei-Li Chen

    National Taiwan University Hospital

    STUDY DIRECTOR

Central Study Contacts

Hsin-Yu y Liu

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 8, 2013

First Posted

December 19, 2013

Study Start

November 1, 2013

Primary Completion

December 1, 2013

Study Completion

November 1, 2014

Last Updated

December 19, 2013

Record last verified: 2013-12

Locations